Recent Advances of Platinum-Based Anticancer Complexes in Combinational Multimodal Therapy

被引:48
作者
Zhong, Tianyuan [1 ,2 ]
Yu, Jie [1 ,2 ]
Pan, Yong [1 ,2 ]
Zhang, Ning [3 ]
Qi, Yanxin [1 ,2 ]
Huang, Yubin [1 ,2 ]
机构
[1] Northeast Normal Univ, Fac Chem, Changchun 130024, Peoples R China
[2] Northeast Normal Univ, Key Lab Sustainable Adv Funct Mat Jilin Prov, Changchun 130024, Peoples R China
[3] Harbin Med Univ, Dept Orthoped, Affiliated Hosp 2, Harbin 150000, Peoples R China
基金
中国国家自然科学基金;
关键词
antitumor effect; combinational therapy; multimodal therapy; platinum drugs; platinum-resistance; SQUAMOUS-CELL CARCINOMA; HEPATOCELLULAR-CARCINOMA; CANCER RECURRENCE; DRUG-DELIVERY; CISPLATIN RESISTANCE; PHOTODYNAMIC THERAPY; RATIONAL DESIGN; NANOFIBER MATS; PT(IV) PRODRUG; TUMOR-CELLS;
D O I
10.1002/adhm.202300253
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Platinum drugs with manifest therapeutic effects are widely used, but their systemic toxicity and the drug resistance acquired by cancer cells limit their clinical applications. Thus, the exploration on appropriate methods and strategies to overcome the limitations of traditional platinum drugs becomes extremely necessary. Combination therapy of platinum drugs can inhibit tumor growth and metastasis in an additive or synergistic manner, and can potentially reduce the systemic toxicity of platinum drugs and overcome platinum-resistance. This review summarizes the various modalities and current progress in platinum-based combination therapy. The synthetic strategies and therapeutic effects of some platinum-based anticancer complexes in the combination of platinum drugs with gene editing, ROS-based therapy, thermal therapy, immunotherapy, biological modelling, photoactivation, supramolecular self-assembly and imaging modality are briefly described. Their potential challenges and prospects are also discussed. It is hoped that this review will inspire researchers to have more ideas for the future development of highly effective platinum-based anti-cancer complexes.
引用
收藏
页数:18
相关论文
共 176 条
[1]   The discovery and development of cisplatin [J].
Alderden, RA ;
Hall, MD ;
Hambley, TW .
JOURNAL OF CHEMICAL EDUCATION, 2006, 83 (05) :728-734
[2]   Mechanistic insight into the cellular uptake and processing of cisplatin 30 years after its approval by FDA [J].
Arnesano, Fabio ;
Natile, Giovanni .
COORDINATION CHEMISTRY REVIEWS, 2009, 253 (15-16) :2070-2081
[3]   Cisplatin: a review of toxicities and therapeutic applications [J].
Barabas, K. ;
Milner, R. ;
Lurie, D. ;
Adin, C. .
VETERINARY AND COMPARATIVE ONCOLOGY, 2008, 6 (01) :1-18
[4]   Adjuvant and Neoadjuvant Chemotherapy for Osteosarcoma: A Historical Perspective [J].
Benjamin, Robert S. .
CURRENT ADVANCES IN OSTEOSARCOMA: CLINICAL PERSPECTIVES: PAST, PRESENT AND FUTURE, 2ND EDITION, 2020, 1257 :1-10
[5]  
Buckingham R, 1997, Eur J Cancer Care (Engl), V6, P59, DOI 10.1111/j.1365-2354.1997.tb00270.x
[6]   Polymers with platinum drugs and other macromolecular metal complexes for cancer treatment [J].
Callari, Manuela ;
Aldrich-Wright, Janice R. ;
de Souza, Paul L. ;
Stenzel, Martina H. .
PROGRESS IN POLYMER SCIENCE, 2014, 39 (09) :1614-1643
[7]   Photocytotoxic Pt(iv) complexes as prospective anticancer agents [J].
Canil, Giovanni ;
Braccini, Simona ;
Marzo, Tiziano ;
Marchetti, Loretta ;
Pratesi, Alessandro ;
Biver, Tanta ;
Funaioli, Tiziana ;
Chiettini, Federica ;
Hoeschele, James D. ;
Gabbiani, Chiara .
DALTON TRANSACTIONS, 2019, 48 (29) :10933-10944
[8]   Photodynamic therapy and anti-tumour immunity [J].
Castano, Ana P. ;
Mroz, Pawel ;
Hamblin, Michael R. .
NATURE REVIEWS CANCER, 2006, 6 (07) :535-545
[9]   Hepatocellular Carcinoma: Current Management [J].
Cha, Charles H. ;
Saif, M. Wasif ;
Yamane, Brett H. ;
Weber, Sharon M. .
CURRENT PROBLEMS IN SURGERY, 2010, 47 (01) :10-67
[10]   A Drug of Such Damned Nature.1 Challenges and Opportunities in Translational Platinum Drug Research [J].
Cheff, Dorian M. ;
Hall, Matthew D. .
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (11) :4517-4532